Long-term efficacy of TARGIT-IORT for breast cancer confirmed
The long-term results of the randomised trial testing the revolutionary procedure - TARGIT-IORT were published by the British Medical Journal on 19 August 2020
Single dose radiotherapy given during lumpectomy for breast cancer (TARGIT-IORT) was found to be as good as conventional post-operative radiotherapy for most women with early breast cancer.
In addition, TARGIT-IORT leads to fewer deaths from causes other than breast cancer, such as heart attacks, lung problems and other cancers.
A short video explains the results
Here is the press-release from University College London that explains the results
https://www.ucl.ac.uk/news/2020/aug/single-dose-radiotherapy-effective-treating-breast-cancer
The scientific summary is shown below - click on it to see the original paper on the BMJ website.
Click here to download the full paper as a PDF File
These results were widely reported in the media such as the lead article in the Times, London, UK, and on social networks
